What Are The Common Findings During Drug Quality Audits In Japan?

Common findings during drug quality audits in Japan include documentation discrepancies, inadequate training records, non-compliance with Good Manufacturing Practices (GMP), insufficient quality control measures, labeling errors, and deviations in standard operating procedures. Auditors often identify issues with equipment calibration, environmental monitoring, and traceability of raw materials, impacting overall product quality and safety.

Leave a Reply

You must be logged in to post a comment.